A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
Clinical trial NCT03562195 · COMPLETED
Trial details
- NCT number
- NCT03562195
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-29
- Primary completion
- 2022-09-07
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.